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Abstract: This study aimed to assess the relationship between platelet volume indices (PVI) and peripheral artery 
disease (PAD). Platelet count (PLT), platelet distribution width (PDW), platelet large cell ratio (P-LCR), and mean platelet 
volume (MPV) were studied in adult patients with PAD. Two hundred ninety two patients were divided into two groups 
according to Fontaine classification. Group-1 contained 183 patients with stage I and II with mild symptoms, and the 
remaining 109 patients referred to the group-2 with severe symptoms. Blood samples were analyzed in a Sysmex SF-
3000 for platelet indices. There were no significant differences between patients in group-1 and group-2 in terms of PVI 
(P>0.05). No significant correlation was identified between severity of peripheral vascular disease and PVI in patients 
with PAD. PVI seem not to associate with severity of PAD. 
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INTRODUCTION 
The pathomechanism of atherosclerosis and PAD is 
a multifactorial phenomenon. Atherosclerosis is an 
inflammatory disorder and platelets play a key role in 
the pathogenesis of vascular diseases. Platelets 
activation is triggered by their interaction with the 
vessel wall. Platelets cover the exposed sub-
endothelial tissue and cause further platelet and 
leukocyte recruitment at the site of vascular injury [1]. 
Platelet volume has been demonstrated to correlate 
with its function. Larger platelets are believed to be 
enzymatically and metabolically more reactive. The 
frequently reported inverse correlation between platelet 
count and MPV reflects the need to preserve a 
constant platelet mass [2]. However, platelet mass 
changes as both platelet count and MPV increase 
during stimulated thrombopoiesis [3]. It has been 
reported that platelet heterogeneity is not related to 
ageing and changes in platelet volume determines by 
megakaryocyte [4]. PVI could therefore be a novel 
marker or a predictor of PAD. 
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PVI are widely available by hematologic 
autoanalysers, and it makes them accessible and 
inexpensive for routine medical practice. Previous 
studies had shown that MPV was elevated in acute 
myocardial infarction (AMI), coronary artery disease 
(CAD), and stroke [5, 6]. The clinical usefulness of 
MPV, PDW, P-LCR, and platelet mass (MPV  platelet 
count) studied in different pathological conditions [7-9]. 
There are also conflicting results in the literature [10]. 
We sought to investigate the relation between PVI and 
severity of peripheral vascular disease. 
PATIENTS AND METHODS 
Two hundred ninety two PAD patient subjects (107 
females, 185 males, mean age 66 years) were enrolled 
in the study at the outpatient clinic of the Department of 
Medicine during the period of 2005-2011. Then, 
patients were divided into two groups according to 
Fontaine classification. Asymptomatic patients and 
patients with mild claudication comprised Group-1 
(Fontaine I and II) and patients with rest pain and 
necrosis and/or gangrene included in group-2 
(Fontaine III and IV). The study was approved by 
Debrecen University Ethics Committee. Signed 
informed consent was obtained from all participants.  
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BIOCHEMICAL ANALYSES 
Peripheral blood was collected after eight hours 
fasting at venipuncture in Vacutainer tubes (Dade 
Behring, Marburg, Germany) for measurement of total 
cholesterol, triglyceride, creatinine (Cobas Integra 700, 
Roche Diagnostics, Mannheim, Germany), and high-
sensitivity CRP (hs-CRP) (Cobas Integra 400, Roche 
Diagnostics, Mannheim, Germany). EDTA anticoagul- 
ated whole blood samples were obtained and analyzed 
by the Sysmex SF3000 analyzer (Sysmex Corpora- 
tion, Kobe, Japan). The samples were processed within 
two hours after venipuncture. PVI were derived from 
the platelet size distribution curve [11]. 
Hyperlipidemia defined as cholesterol more than 5.2 
mmol/l and/or triglyceride more than 1.7 mmol/l or 
administration of lipid-lowering agents. Hypertension 
was defined as blood pressure exceeding systolic 140 
mmHg and/or diastolic 90 mmHg, and/or receiving 
antihypertensive treatment. Diabetes mellitus was 
defined as a fasting glucose 7 mmol/L, a non-fasting 
glucose 11.1 mmol/L, or treatment for diabetes. 
Cigarette smoking history was self-reported. Height 
and body weight were measured with participants 
standing without shoes and other heavy garments. 
Body mass index was calculated as weight (kg)/ 
height
2
(m). All laboratory and vascular measurements 
were carried out by technicians unaware of the 
subjects' history of PAD. 
DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE 
The diagnosis of PAD was based on the ankle 
brachial pressure index [12], which has been 
previously validated [13], and test results have been 
shown to have high reproducibility when performed by 
trained personnel [14]. Ankle/brachial ratio was 
considered to be indicative of PAD if less than or equal 
to 0.9 [15]. 
STATISTICAL ANALYSIS 
Values are expressed as mean ± standard deviation 
(SD), or median (25%-75% confidence interval). 
Descriptive statistics were calculated to summarize the 
clinical features of PAD patients. SPSS software 
(version 18; SPSS Inc., Chicago, IL, USA) was used to 
perform all analyses. All tests were twotailed 
comparisons and P less than 0.05 was considered as 
statistically significant. The normality of distribution of 
continuous variables was assessed using the 
KolmogorovSmirnov test. Comparisons between 
groups were performed with the 2test for binary and 
categorical data and the Student’s ttest or Mann-
Whitney U test for continuous variables. 
RESULTS 
Table 1. summarises the clinical and demographic 
aspects of patients. There were a similar proportion of 
diabetes mellitus, smokers, and hypertensive 
individuals between group-1 and group-2. The degree 
of hyperlipidemia, hs-CRP and creatinine in the two 
patient groups was not significantly different. Platelet 
count, MPV, PDW, and P-LCR did not differ between 
two groups of patients. These findings are summarized 
in Table 2. MPV was significantly and inversely 
correlated to platelet count in all patients (r = -0.421) 
and two groups (group-1: r = -0.403; group-2: r = -0.46) 
separately. Estimating the Receiver operating 
characteristic (ROC) curve area under the curve (AUC) 
showed that PVI has no discriminating power for 
predicting severity of PAD, separately or combined 
(Figures 1 and 2). 
Table 1: Demographic Features and Baseline Clinical 
Characteristics of Study Population with 
Peripheral Artery Disease, in Group-1 and 2 
 Patients 
(n=292) 
Group-1 
(n=183) 
Group-2 
(n=109) 
Male, n (%) 185 (63) 113 (63.1) 68 (63.5) 
Age (years) 66 ± 12 66 ± 13 67 ± 12 
Hyperlipidemia, n (%) 219 (75) 126 (70.4) 85 (79.4) 
Smoking, n (%) 105 (36) 58 (32.4) 44 (41.1) 
Hypertension, n (%) 175 (60) 112 (62.6) 61 (57) 
Diabetes mellitus, n (%) 72 (25) 42 (23.5) 29 (27.1) 
BMI (kg/m
2
) 24.7 ± 2.8 24.7 ± 2.7 24.7 ± 3.0 
hs-CRP (mg/l) 3.0 (1.9-5.2) 2.5 (1.9-4.6) 3.7 (2.4-6.0) 
WBC count ( 109/l) 7.2 ± 2.0 7.1 ± 1.9 7.3 ± 2.1 
Creatinine (mol/l) 82 (76-90) 82 (76-93) 81.5 (76-88) 
Triglyceride (mmol/l)  1.5 (1.2-2.0) 1.5 (1.2-2.0) 1.5 (1.3-2.0) 
Cholesterol (mmol/l) 5.7 ± 1.2 5.5 ± 1.2 5.9 ± 1.2 
LDL-cholesterol (mmol/l) 3.5 ± 1.1 3.3 ± 1.1 3.5 ± 1.0 
HDL-cholesterol (mmol/l) 1.3 (1.2-1.5) 1.4 ±0.4 1.4 ±0.5 
ApoA-I (g/l) 1.5 ± 0.3 1.5 ± 0.3 1.5 ± 0.3 
ApoB-100 (g/l) 1.1 ± 0.3 1.1 ± 0.3 1.1 ± 0.3 
Lp(a) (mg/l) 144 (75-277) 143 (75-281) 162 (76-267) 
 
Data are expressed as median (inter-quartile range) or mean ± SD; 
BMI, body mass index; WBC, White blood cell; hs-CRP, high 
sensitive C-reactive protein. 
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Table 2: Platelet Volume Indices in Study Population with 
Peripheral Artery Disease, in Groups 1 and 2* 
 Patients 
(n=292) 
Group-1 
(n=183) 
Group-2 
(n=109) 
Platelet count  
( 109/l) 196 (170-220) 204 ± 72 206 ± 66 
Mean platelet 
volume (fl) 
10.3 (9.8-10.7) 10.3 ± 1.0 10.4 ± 1.1 
Platelet distribu- 
tion width (fl) 
12.5 (11.5-13.2) 12.3 (11.3-13.1) 12.8 (11.6-13.6) 
Platelet large 
cell ratio (%) 
28.7 (24.9-31.8) 28.4 ± 7.8 30.1 ± 9.2 
Platelet mass 2076 ± 628 2059 ± 649 2014 ± 595 
 
Data are expressed as median (inter-quartile range) or mean ± SD. 
*P-value for all comparisons between group-1 and group-2 were 
>0.05 
 
Figure 1: Receiver operating characteristic curve analysis for 
prediction of peripheral artery disease by platelet volume 
indices. 
The area under the curve (95% confidence interval; P) is: 
platelet count 0.493 (0.416-0.57; 0.852), MPV 0.450 (0.374-
0.526; 0.191), PDW 0.457 (0.381-0.532; 0.255), P-LCR 0.449 
(0.373-0.525; 0.18). 
CONCLUSIONS 
We investigated the relationship between PVI and 
PAD. PVI are routinely measured by automated 
hematology analyzers. Platelets are implicated in the 
pathogenesis of vascular disorders, including athero- 
sclerosis and its complications, such as AMI, and 
stroke. Abnormal platelet volume may indicate altered 
platelet reactivity and potential vascular risk [16]. 
Platelet volume may increase due to the 
accelerated platelet turnover with higher level of 
reticulated platelets from bone marrow [17]. PVI have 
been investigated extensively in different pathological 
conditions.  
 
 
 
 
 
 
Figure 2: Receiver operating characteristic curve analysis for 
prediction of peripheral artery disease by combined effect of 
platelet volume indices. 
The area under the curve 0.461 (95% confidence interval 
0.385-0.536; P=0.304). 
Several reports have demonstrated that changes in 
MPV and PDW have been linked to increased risk of 
CAD, AMI, stroke and the level of circulating auto 
antibodies and inflammatory agents [18-20]. Whereas 
other demonstrate that MPV and PDW are not 
associated with increased risk of cardiovascular 
diseases [21, 22]. 
Khandekar and coworkers found significantly higher 
P-LCR in patients with AMI and unstable angina 
compare to control individuals. On the other hand, De 
Luca et al. failed to demonstrate an association 
between P-LCR and CAD [23, 24]. There was an 
inverse relation between platelet count and MPV. 
Preserved constant platelet mass reflects the tendency 
to maintain hemostasis in different conditions [2]. The 
platelet mass alteration was not significantly different 
between stroke patients and control individuals [25]. 
PVI do not retain clinical relevance as confirmed by the 
results of the ROC curve analysis. In a literature search 
of PAD, we found few reports about PVI and PAD. 
Berger et al. has demonstrated increased MPV in 
patients with PAD [26]. A positive correlation between 
MPV and arterial stiffness was shown in healthy 
individuals by Wang et al [27]. In conclusion, we found 
that PVI are not associated with the extent of PAD.  
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